Application of Carnitine to Children with Carditis on the Background of Community - Acquired Pneumonia
Keywords:
carnitine, myocarditis, community-acquired pneumonia, childrenAbstract
Pneumonia in children is one of the urgent problems in pediatrics, which is determined by the continuing high incidence and severe prognosis, especially in young children. The aim of the study was to evaluate the effectiveness of the use of carnitine in the treatment and prevention of myocarditis in children with community acquired pneumonia. We examined 84 children aged 1 to 5 years with pneumonia, which we divided into 2 groups. Group I (control) included 42 children who were on standard treatment. Group II (main) included 42 sick children with pneumonia, who had a violation of the cardiovascular system and parenterally received the drug carnitine. The results obtained underline that the use of carnitine for pneumonia in children reduces the risk of severe unwanted heart complications and reduces the length of hospital stay by an average of 1.8 bed-days in comparison with standard therapy.
References
Basargina E.N. Myocarditis in children: a manual for doctors / E.N. Basargina. - M., 2008. - 27 p.
Clinical and etiological characteristics of community-acquired pneumonia in children and analysis of the effectiveness of antimicrobial therapy / Tsarkova S.A., Beikin Ya.B., Shilova V.P. et al. // Issues of modern pediatrics.-2002.-Vol.1, No.6.-P.32-36.
Clinical guidelines for pediatric cardiology and rheumatology / edited by M.A. Shkolnikova, E.I. Alekseeva. - M., 2011. - 143 p.
Kardjavova G.A., Mukhammadiev I.S. Acute myocarditis in children in the background of community-acquired pneumonia: clinical features Multidisciplinary Scientific Journal Scholar ISSN: 2181-4147 Volume 2 | Issue 3 | January, 2024 p.15-21.
Pogosov S. et al. Psychogenetic properties of drug patients as risk factors for the formation of addiction //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 186-191.
Sedenkova M. et al. The possibility of predicting the time of formation and development of alcohol dependence: the role of genetic risk, family weight and its level //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 173-178.
Shamilov V. et al. Disorders of decision-making in the case of depression: clinical evaluation and correlation with eeg indicators //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 198-204.
Uskov A. et al. Modern methods of therapeutic fasting as a way to overcome the pharmacoresistance of mental pathology //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 179-185.
Prostyakova N. et al. Strategy for early diagnosis with cardiovascular diseaseisomatized mental disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 166-172.
Tahirova, J., Roziklov, N., Mamatkulova, F., & Shernazarov, F. (2022). Insomnia problem causes of sleep disorder, help measures at home. Science and innovation, 1(D8), 521-525.
Qizi T. J. I., Farrukh S. Treatment of myocardial infarction and first aid //Science and innovation. – 2022. – Т. 1. – №. D3. – С. 317-320.
Rotanov A. et al. Elderly epilepsy: neurophysiological aspects of non-psychotic mental disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 192-197.
Abdurakhmanov I., Shernazarov F. SPECIFIC ASPECTS OF TREATMENT OF CHRONIC RHINOSINUSITIS IN CHILDREN //Science and innovation. – 2023. – Т. 2. – №. D10. – С. 164-168.
Tahirova J. et al. Neurose causes and mechanisms of development, symptoms, treatment, prevention //Science and innovation. – 2022. – Т. 1. – №. D8. – С. 515-520.
Tahirova J., Shernazarov F. Symptoms of hymoritis, treatment, methods of folk medicine, prevention //Science and innovation. – 2022. – Т. 1. – №. D8. – С. 983-990.
Shodiyeva D., Shernazarov F. Analysis of the compounds providing antihelmitic effects of chichorium intybus through fractionation. Science and innovation, 2 (D2), 64-70. – 2023.
Jalalova D., Normatova N., Shernazarov F. Genetic markers for the development of diabetic retinopathy //Science and Innovation. – 2022. – Т. 1. – №. 8. – С. 919-923.
Abdukodirova S., Shernazarov F. SPECIFIC CHARACTERISTICS AND TREATMENT OF ACUTE OBSTRUCTIVE BRONCHITIS IN CHILDREN OF EARLY AGE //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 5-8.
Kardjavova G.A., Rakhmonov R.N., Zubaydullayev S.V. Acute myocarditis in childre on the background of broncho-pulmonary diseases Multidisciplinary Scientific Journal January, 2024 Golden brain ISSN: 2181-4120 volume 2 | issue 3 | 2024 p.70-75.
Karjavova G.A., Rakhmonov R.N., Acute myocarditis in children against the background of community-acquired pneumonia: features of the clinical picture Scientific journal ERUS ISSN: 2181-3515 Volume 3 | Special Issue 3 | January 2024. P-395-400.
Karzhavova G.A. Rakhmonov R.N. New approaches for the etiological aspects of community-acquired pneumonia in children Scientific journal ERUS ISSN: 2181-3515 Volume 3 | Special Issue 3 | January 2024. P-389-394.
Streljaeva, A.V. Toxic cardiopathy and myocarditis of paecilomycosis and other etiology in children / A.V. Streljaeva, H.N. Shadyeva, N.B. Lazareva [et al.] // Russian journal of cardiology. - 2010. - No. 3. - P.46-52.
